Flossbach Von Storch
IDXX icon

Flossbach Von Storch’s Idexx Laboratories IDXX Stock Holding History

Flossbach Von Storch’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.09M Sell
17,270
-764
-4% -$429K 0.04% 73
2026
Q1 		$10.1M Sell
18,034
-36,097
-67% -$23.1M 0.05% 73
2025
Q4 		$36.6M Sell
54,131
-56,403
-51% -$38.4M 0.15% 59
2025
Q3 		$70.6M Sell
110,534
-130,591
-54% -$79.3M 0.28% 48
2025
Q2 		$129M Sell
241,125
-310,639
-56% -$149M 0.53% 33
2025
Q1 		$232M Buy
551,764
+78,428
+17% +$34.1M 1% 28
2024
Q4 		$196M Buy
473,336
+464,791
+5,439% +$204M 0.78% 31
2024
Q3 		$4.32M Buy
8,545
+5,215
+157% +$2.53M 0.02% 87
2024
Q2 		$1.62M Buy
3,330
+281
+9% +$141K 0.01% 108
2024
Q1 		$1.65M Hold
3,049
– – 0.01% 106
2023
Q4 		$1.69M Buy
+3,049
New +$1.43M 0.01% 106

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Flossbach Von Storch's IDXX Position: Q2 2026 in Review

Flossbach Von Storch reduced its Idexx Laboratories (IDXX) stake by 4.2% in Q2 2026, selling an estimated $429K and leaving 17,270 shares worth $9.09M. The position accounts for 0.04% of the portfolio, ranked #73.

Flossbach Von Storch first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $232M in Q1 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Flossbach Von Storch held 17,270 shares of Idexx Laboratories worth $9.09M as of Q2 2026.
  • Flossbach Von Storch sold 764 Idexx Laboratories shares in Q2 2026, an estimated $429K.
  • Idexx Laboratories made up 0.04% of Flossbach Von Storch's portfolio in Q2 2026, its #73 holding.
  • Flossbach Von Storch first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Flossbach Von Storch's Idexx Laboratories position peaked at $232M in Q1 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Flossbach Von Storch's 13F filing for Q2 2026, filed 10 Aug 2026.